Nitric oxide metabolites (nitrite and nitrate) in several clinical condition

Clinical Hemorheology and Microcirculation

Volumn 56, Issue 4, 2014, Pages 359-369

  Caimi, G ^a   Hopps, E ^a   Montana, M ^a   Carollo, C ^a   Calandrino, V ^a   Incalcaterra, E ^a   Canino, B ^a   Lo Presti, R ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

AMI; dialysis; hypertension; kidney disease; metabolic syndrome; NOx; OSAS; sistemic sclerosis

Indexed keywords

NITRATE; NITRITE; NITRIC ACID DERIVATIVE; NITRIC OXIDE;

ACUTE HEART INFARCTION; ADULT; APNEA HYPOPNEA INDEX; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONCENTRATION (PARAMETERS); CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; METABOLITE; RAYNAUD PHENOMENON; RENAL REPLACEMENT THERAPY; SLEEP DISORDERED BREATHING; SMOKING; SYSTEMIC SCLEROSIS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; METABOLISM; MIDDLE AGED; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84901756461     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-131758     Document Type: Article

References (80)

1. K. Akiyama, A. Kimura, H. Suzuki, Y. Takeyama, T.L. Gluckman, A. Terhakopian, T. Katagiri, K.Y. Suh, J. Roseto and R.J. Ring, Production of oxidative products of nitric oxide in infarcted human heart, Journal of Molecular and Cellular Cardiology 32 (1998), 373-379. (Pubitemid 28396485)
2. K. Akiyama, H. Suzuki, P. Grant and R.J. Bing, Oxidant products of nitric oxide,NO2and NO3, in plasma after experimental myocardial infarction, Journal of Molecular and Cellular Cardiology 29 (1997), 1-9. (Pubitemid 27129125)
3. K.G. Alberti, P. Zimmet and J. Shaw, Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation, Diabetic Medicine 23 (2006), 469-480.
4. Y. Allanore, D. Borderie, P. Hilliguin, A. Nernvann, M. Levacher, H. Lemarechal, O.G. Ekindjian and A. Kahan, Low levels of nitric oxide (NO) in systemic sclerosis: Inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells, Rheumatology (Oxford) 40 (2001), 1089-1096.
5. G.N. Andersen, K. Caidahl, E. Kazzam, A.S. Petersson, A.Waldenstrom, L. Mincheva-Nilsson and S. Rantapaa-Dahlqvist, Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis, Arthritis & Reumatism 43 (2000), 1085-1093.
6. M.C. Armas-Padilla, M.J. Armas-Hernandez, B. Sosa-Chanache, R. Cammarata, B. Pacheco, J. Guerrero, A.R. CArvajal, R. Hernandez-Hernandez, Z.H. Israili and M. Valasco, Nitric oxide and malonildialdehyde, American Journal of Therapeutics 14 (2007), 172-176.
7. S.Z. Asl, A. Ghasemi and F. Azizi, Serum nitric oxide metabolites in subjects with metabolic syndrome, Clinical Biochemistry 41 (2008), 1342-1347.
8. A. Aydin, H. Orhan, A. Sayal, M. Ozata, G. Sahin and A. Isimer, Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: Effects of glycemic control, Clinical Biochemistry 34 (2001), 65-70. (Pubitemid 32178508)
9. C.R. Balistreri, S. Vasto, F. Listí, M.P. Grimaldi, D. Lio, G. Colonna-Romano, M. Caruso, G. Caimi, E. Hoffman, C. Caruso and G. Candore, Association between +1059G/C CRP polymorphism and acute myocardial infarction in a cohort of patients from Sicily: A pilot study, Annals of the New York Academy of Science 1067 (2006), 267-281.
10. R.H. Boger and C. Zoccali, ADMA: A novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease, Atherosclerosis 4 (2003), 23-28. (Pubitemid 38234491)
11. G. Caimi, C. Carollo, M. Montana, R. Iatrino, B. Bondí and R. Lo Presti, Nitric oxide metabolites, leukocyte activation markers and oxidative status in dialyzed subjects, Blood Purification 27 (2009), 194-198.
12. G. Caimi, C. Carollo, M. Montana, F. Vaccaro and R. Lo Presti, Elastase, myeloperoxidase, nitric oxide metabolites and oxidative status in subjects with clinical stable chronic renal failure on conservative treatment, Clin Hemorheol Microcirc 43 (2009), 251-256.
13. G. Caimi, E. Hopps, M. Montana, D. Noto, B. Canino, R. Lo Presti and M.R. Averna, Evaluation of nitric oxide metabolites in a group of subjects with metabolic syndrome, Diabetes & Metabolic Syndrome 6 (2012), 132-135.
14. G. Caimi, M. Montana, V. Calandrino, M. Caruso, C. Carollo, A. Catania and R. Lo Presti, Nitric oxide metabolites (nitrite and nitrate) in young patients with recent acute myocardial infarction, Clin Hemorheol Microcirc 40 (2008), 157-163.
15. G. Caimi, G. Mulè, E. Hopps, C. Carollo and R. Lo Presti, Nitric oxide metabolites and oxidative stress in mild essential hypertension, Clin Hemorheol Microcirc 46 (2010), 321-325.
16. P. Chedraui, G.S. Escobar, C. Ramirez, F.R. Perez-Lopez, L. Hidalgo, P. Mannella, A. Genazani and T. Simoncini, Nitric oxide and pro-inflammatory cytokine serum levels in postmenopausal women with the metabolic syndrome, Gynecological Endocrinology 28 (2012), 787-791.
17. W.Y. Chien, K.D. Yang, H.L. Eng, Y.H. Hu, P.Y. Lee, S.T. Wang and P.W. Wang, Increased plasma concentration of nitric oxide in type 2 diabetes but not in nondiabetic individuals with insulin resistance, Diabetes & Metabolism 31 (2005), 63-68. (Pubitemid 40327594)
18. J.W. Choi, Enhanced nitric oxide production is closely associated with serum lipid concentrations in adolescents, Clinica Chimica Acta 347 (2004), 151-156. (Pubitemid 39099617)
19. G. Ciuffetti, L. Pasqualini, M. Pirro, R. Lombardini, M. de SIO, G. Schillaci and E. Mannarino, Blood rheology in men with essential hypertension and capillary rarefaction, Journal of Human Hypertension 16 (2002), 533-537. (Pubitemid 35021359)
20. K. Cosby, K.S. Partovi, J.H. Crawford, R.P. Patel, C.D. Reiter, S. Martyr, B.K. Yang, M.A. Waclawiw, G. Zalos, X. Xu, K.T. Huang, H. Shields, D.B. Kim-Shapiro, A.N. Schecher, R.O. Cannon 3rd and M.T. Gladwin, Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation, Nature Medicine 9 (2003), 1498-1505. (Pubitemid 38004777)
21. G. Cotter, E. Kaluski, O. Milo, A. Blatt, A. Salah, A. Hendler, R. Krakover, A. Golick and Z. Vered, LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock, European Heart Journal 24 (2003), 1287-1295. (Pubitemid 36917699)
22. R.T. de Jong, E.H. Sernè, R.G. Ijzerman, G. de Vries and C.D.A. Stehouwer, Impaired microvascular function in Obesity, Circulation 109 (2004), 2529-2535.
23. M. Del Ben, M. Fabiani, L. Loffredo, L. Polimeni, R. Carnevale, F. Baratta, M. Brunori, F. Albanese, T. Augelletti, F. Violi and F. Angelico, Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment, BMC Pulmonary Medicine 12 (2012), 36.
24. L. Di Renzo, F. Galvano, C. Orlandi, A. Bianchi, C. Di Giacomo, L. La Fauci, R. Acquaviva and A. De Lorenzo, Oxidative stress in normal-weight obese syndrome, Obesity 18 (2010), 2125-2130.
25. A. Dooley, B. Gao, N. Bradley, D.J. Abraham, C.M. Black, M. Jacobs and K.R. Burkdorfer, Abnormal nitric oxide metabolism in systemic sclerosis: Increased levels of nitrated proteins and asymmetric dimethylarginine, Rheumatology (Oxford) 45 (2006), 676-684. (Pubitemid 43985335)
26. V. Dzavik, G. Cotter, H.R. Reynolds, J.H. Alexander, K. Ramanathan, A.L. Stebbins, D. Hathaway, M.E. Farkouh, E.M. Ohman, D.A. Baran, R. Prondzinsky, J.A. Panza, W.J. Cantor, Z. Vered, C.E. Buller, N.S. Kleiman, J.G. Webb, D.R. Holmes, J.E. Parrillo, S.L. Hazen, S.S. Gross, R.A. Harrington and J.S. Hochman, Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: A phase II dose-ranging study, European Heart Journal 28 (2007), 1109-1116. (Pubitemid 47343883)
27. B. Fagrell, Microcirculatory methods for the clinical assessment of hypertension, hypotension and ischemia, Annals of Biomedical Engineering 14 (1986), 163-173. (Pubitemid 16096447)
28. S. Forconi and T. Gori, Endothelium and hemorheology, Clin Hemorheol Microcirc 53 (2013), 3-10.
29. U. Forstermann, H. Kleinert, I. Gath, P. Schwarz, E.I. Closs and N.J. Dun, Expression and expressional control of nitric oxide synthases in various cell types, Advances in Pharmacology 34 (1995), 171-186.
30. C.M. Franco, A.M. Lima, L. Ataide Jr., O.G. Lins, C.M. Castro, A.A. Bezerra, M.F. de Oliveira and J.R. Oliveira, Obstructive sleep apnea severity correlates with cellular and plasma oxidative stress parameters and affective symptoms, Journal of Molecular Neuroscience 47 (2012), 300-310.
31. A. Ghasemi, S. Zahedi Asl, Y. Mehrabi, N. Saadat and F. Azizi, Serum nitric oxide metabolite levels in a general healthy population: Relation to sex and age, Life Sciences 83 (2008), 326-331.
32. R. Ginnan, B.J. Guikema, K.E. Halligan, H.A. Singer and D. Jourd'heuil, Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases, Free Radical Biology and Medicine 44 (2008), 1232-1245.
33. T. Gori, A. Damaske, S. Muxel, M.C. Radmacher, F. Fasola, S. Schaefer, M. Fineschi, S. Forconi, F. Jung, T. Munzel and J.D. Parker, Endothelial function and hemorheological parameters modulate coronary blood flow in patients without significant coronary artery disease, Clin Hemorheol Microcirc 52 (2012), 255-266.
34. M.P. Grimaldi, G. Candore, S. Vasto, M. Caruso, G. Caimi, E. Hoffman, G. Colonna-Romano, D. Lio, Y. Shinar, C. Franceschi and C. Caruso, Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: A study in the Sicilian population, Journal of Leukocyte Biology 79 (2006), 611-615. (Pubitemid 44831237)
35. H. Higashino, H. Miya, H. Mukai and Y. Miya, Serum nitric oxide metabolite (NOx) levels in hypertensive patients at rest: A comparison of age, gender, blood pressure and complications using normotensive controls, Clinical and Experimental Pharmacology and Physiology 34 (2007), 725-731. (Pubitemid 47013483)
36. H. Higashino, M. Tabuchi, S. Yamagata, T. Kurita, H. Miya, H. Mukai and Y. Miya, Serum nitric oxide metabolite levels in groups of patients with various diseases in comparison of healthy control subjects, Journal of Medical Sciences 10 (2010), 1-11.
37. F. Jung,W.Kolepke, S. Spitzer,H. Kiesewetter,K.W. Ruprecht, R. Bach, H. Schieffer and E.Wenzel, Primary and secondary microcirculatory disorders in essential hypertension, Clinical Investigation 71 (1993), 132-138. (Pubitemid 23051323)
38. K.Kedziora-Kornatowska, J. Czuczejko, H. Pawluk, T.Kornatowski, J. Motyl, L. Szadujkis-Szadurski, K. Szewczyk-Golec and J. Kedziora, The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension, Cellular and Molecular Biology Letters 9 (2004), 635-641. (Pubitemid 40065189)
39. C.A. Kumar and U.N. Das, Lipid peroxides, anti-oxidants and nitric oxide in patients with pre-eclampsia and essential hypertension, Medical Science Monitor 6 (2000), 901-907.
40. L. Lavie, A. Hefetz, R. Luboshitzky and O. Lavie, Plasma levels of nitric oxide and L-arginine in sleep apnea patients, Journal of Molecular Neuroscience 21 (2003), 57-63. (Pubitemid 37204873)
41. D. Lio, G. Candore, A. Crivello, L. Scola, G. Colonna-Romano, L. Cavallone, E. Hoffman, M. Caruso, F. Licastro, C.M. Caldarera, A. Branzi, C. Franceschi and C. Caruso, Opposite effects of interleukin 10 common gene polymorphism in cardiovascular diseases and in successful ageing: Genetic background of male centenarians is protective against coronary heart disease, Journal of Medical Genetics 41 (2004), 790-794. (Pubitemid 39389298)
42. F. Listí, G. Candore, D. Lio, L. Cavallone, G. Colonna-Romano, M. Caruso, E. Hoffman and C. Caruso, Association between platelet endothelial cellular adhesion molecule 1 (PECAM-1/CD31) polymorphism and acute myocardial infarction: A study in patients from Sicily, European Journal of Immunogenetics 31 (2004), 175-178. (Pubitemid 39049862)
43. F. Listí, G. Candore, D. Lio, M. Russo, G. Colonna-Romano, M. Caruso, E. Hoffman and C. Caruso, Association between C1019T polymorphism of connexyn37 and acute myocardial infarction: A study in patients from Sicily, International Journal of Cardiology 102 (2005), 269-271. (Pubitemid 40854041)
44. A. Lopez, A.L. Lorente, J. Steingrub, J. Bakker, A. McLuckie, S. Willatts, M. Brockway, A. Anzueto, L. Holzapfel, D. Breen, M.S. Silverman, J. Takala, J. Donaldson, C. Aneson, G. Grove, S. Grossman and R. Grover, Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock, Critical Care Medicine 32 (2004), 21-30. (Pubitemid 38125559)
45. R. Lo Presti, C. Carollo, M. Montana, F. Vaccaro and G. Caimi, Nitric oxide metabolites in chronic renal failure in conservative and in hemodialysis treatment, Trace Elements and Electrolites 25 (2008), 211-212.
46. R. Lo Presti, A. Catania, T. Dámico, M. Montana, M. Caruso and G. Caimi, Oxidative stress in young subjects with acute myocardial infarction: Evaluation at the initial stage and after 12 months, Clinical and Applied Thrombosis and Hemostasis 14 (2008), 421-427.
47. R. Lo Presti, G. Milio, D. Lucido, G. Amodeo, C. Carollo and G. Caimi, Stress ossidativo in pazienti con sclerodermia: Effetti dellíloprost, Minerva Cardioangiologica 55 (2007), 179-180.
48. C.M. Loughrey, I.S. Young, J.H. Lightbody, D. McMaster, P.T. McNamee and E.R. Trimble, Oxidative stress in haemodialysis, Quarterly Journal of Medicine 87 (1994), 679-683.
49. J.O. Lundberg and M. Govoni, Inorganic nitrate is a possible source for systemic generation of nitric oxide, Free Radical Biology and Medicine 37 (2004), 395-400. (Pubitemid 38834005)
50. I.M.J.Mackenzie, A. Ekangaki, J.D.Young and C.S. Garrard, Effect of renal function on serum nitrogen oxide concentration, Clinical Chemistry 42 (1996), 440-444. (Pubitemid 26080933)
51. A. Mazzone, C. Cusa, L. Bucci, M. Vezzoli, S. Ghio, I. Buggia, M.B. Regazzi, G. Fossati, I. Mazzucchelli and D. Gritti, The effect of iloprost infusion on microcirculation is independent of nitric oxide metabolites and endothelin-1 in chronic peripheral ischemia, European Journal of Clinical Investigation 29 (1999), 1-5. (Pubitemid 29084241)
52. C.J. Menkes, Y. Allanore, D. Borderie, P. Hilliquin, A. Hernvann, O. Ekindjian and A. Kahan, Inducible nitric oxide synthase expression and nitric oxide production by monocytes in systemic sclerosis, Bulletin de lácademie Nationale de Medicine 185 (2001), 509-522.
53. T.M. Millar, C.R. Stevens, N. Benjamin, R. Eisenthal, R. Harrison and D.R. Blake, Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions, FEBS Letters 427 (1998), 225-228. (Pubitemid 28225062)
54. A. Modin, H. Bjorne, M. Herulf, K. Alving, E. Weitzberg and J.O. Lundberg, Nitrite derived nitric oxide: A possible mediator of ácidic-metabolic' vasodilation, Acta Physiologica Scandinavica 171 (2001), 9-16. (Pubitemid 32324395)
55. M.Y. Mok, P.C.W. Fung, C. Ooi, H.F. Tse, Y. Wong, Y.M. Lam, W.S. Wong and C.S. Lau, Serum nitric oxide metabolites and disease activity in patients with systemic sclerosis, Clinical Rheumatology 27 (2008), 315-322.
56. S. Moncada, R.M.J. Palmer and E.A. Higgs, Nitric oxide: Physiology, pathophysiology and pharmacology, Pharmacological Reviews 43 (1991), 109-142.
57. C. Nathan, Inducible nitric oxide synthase: What difference does it make? Journal of Clinical Investigation 100 (1997), 2417-2423. (Pubitemid 27514879)
58. S.J. Nicholls, Z. Wang, R. Koeth, B. Levison, B. Del Fraino, V. Dzavik, O.W. Griffith, D. Hathaway, J.A. Panza, S.E. Nissen, J.S. Hochman and S.L. Hazen, Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction, Circulation 116 (2007), 2315-2324. (Pubitemid 350100338)
59. M. Olszanecka-Glinianowicz, B. Zahorska-Markiewicz, J. Janowska and A. Zurakowski, Serum concentration of nitric oxide, tumor necrosis factor (TNF)-a and TNF soluble receptors in women overweight and obesity, Metabolism Clinical and Experimental 10 (2004), 1268-1273. (Pubitemid 39222086)
60. S.M. Ouvina, R.D. La Greca, N.L. Zanaro, L. Palmer and B. Sassetti, Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and dyabetic type II patients, Thrombosis Research 102 (2001), 107-114. (Pubitemid 32373219)
61. J. Oyama, H. Yamamoto, T. Maeda, A. Ito, K. Node and N. Makino, Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome, Clinical Cardiology 35 (2011), 231-236.
62. S. Ozden, S. Tatlipinar, N. Bicer, V. Yaylali, C. Yildirim, D. Ozbay and G. Guner, Basal serum nitric oxide levels in patients with type 2 diabetes mellitus and different stages of retinopathy, Canadian Journal of Ophthalmology 38 (2003), 393-396. (Pubitemid 37295125)
63. F.O. Pereira, T.S. Frode and Y.S. Medeiros, Evaluation of tumor necrosis alpha, interleukin-2, soluble receptor, nitric oxide metabolites, and lipid as inflammatory markers in type 2 diabetes mellitus, Mediators of Inflammation 2006 (2006), 39062.
64. M. Saitoh, T. Osanai, T. Kamada, T. Matsunaga, H. Ishizaka, H. Hanada and K. Okumura, High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: Role in reduction of plasma nitric oxide level, Heart Vessels 18 (2003), 177-182. (Pubitemid 37258670)
65. R. Salem and A. Mebazaa, Nitric oxide inhibition rapidly increases blood pressure with no change in outcome in cardiogenic shock: The TRIUMPH trial, Critical Care 11 (2007), 136-137.
66. R. Schulz, D. Schmidt, X. Lopes-Ribeiro, C. Lucke, K. Mayer, H. Olschewski, W. Seeger and F. Grimminger, Decrease plasma levels of nitric oxide deirvatives in obstructive sleep apnoea: Response to cPAP therapy, Thorax 55 (2000), 1046-1051.
67. A. Sud, M. Khullar, A. Wanchu and P. Bambery, Increased nitric oxide production in patients with systemic sclerosis, Nitric Oxide 4 (2000), 615-619. (Pubitemid 32053273)
68. R.H. Surekha, B.B.M.V. Srikanth, P. Jharna, R.V. Ramachandra, R.V. Dayasagar and A. Jyothy, Oxidative stress and total antioxidant status in myocardial infarction, Singapore Medicine 48 (2007), 137-142. (Pubitemid 351229415)
69. K. Takagi, Y. Kawaguchi, M. Hara, T. Sugiura, M. Harigai and N. Kamatani, Serum nitric oxide (NO) levels in systemic sclerosis patients: Correlation between NO levels and clinical features, Clinical and Experimental Immunology 134 (2003), 538-544. (Pubitemid 37542097)
70. The Triumph Writing Committee, Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock. The TRIUMPH randomized controlled trial, JAMA 297 (2007), 1657-1666.
71. P. Ulker, F. Gunduz, H.J. Meiselman and O.K. Baskurt, Nitric oxide generated by red blood cells following exposure to shear stress dilates isolated small mesenteric arteries under hypoxic condition, Clinical Hemorheology and Microcirculation, 2012 Oct 17, [Epub ahead of print].
72. P. Ulker, L. Sati, C. Celik-Ozenci, H.J. Meiselman and O.K. Baskurt, Mechanical stimulation of nitric oxide sunthesizing mechanisms in erythrocytes, Biorheology 46 (2009), 121-132.
73. P. Ulker, N. Yaras, O. Yalcin, C. Celik-Ozenci, P.C. Johnson, H.J. Meiselman and O.K. Baskurt, Shear stress activation of nitric oxide synthase and increased nitric oxide levels in human red blood cell, Nitric Oxide-Biology and Chemistry 24 (2011), 184-191.
74. T. Vyzantiadis, A. Karagiannis, S. Douma, P. Harsoulis, A. Vyzantiadis and C. Zamboulis, Vascular endothelial growth factor and nitric oxide serum levels in arterial hypertension, Clinical and Experimental Hypertension 28 (2006), 603-609. (Pubitemid 44581975)
75. J.B. Weinberg, Nitric oxide production and nitric oxide syntases type 2 expression by human mononuclear phagocytes - a review, Molecular Medicine 4 (1998), 557-591. (Pubitemid 28523111)
76. S.M. Wildhirt, R.R. Dudek, H. Suzuki, and R.J. Bing, Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction, International Journal of Cardiology 50 (1995), 253-261.
77. T. Yamamoto, I. Katayama and K. Nishioka, Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis, Journal of Rheumatology 25 (1998), 314-317. (Pubitemid 28088261)
78. J.W. Yoon, M.V. Pahl and N.D. Vaziri, Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease, Kidney International 71 (2007), 167-172. (Pubitemid 46094691)
79. I. Zavaroni, D. Ardigo, P.C. Rossi, A. Zuccarelli, E. Pacetti, L. Monti, P.M. Piatti and G.M. Reaven, Relationship between plasma nitric oxide concentration and insulin resistance in essential hypertension, American Journal of Hypertension 17 (2004), 549-552. (Pubitemid 38844979)
80. D.L. Zhang, H. Liao, Y.Y.Wei, Y. Zhang, Q.D. Zhang and Z.G.Wang, Elevation in serum apelin-13 is positively correlated with ADMA in patients on maintenance hemodialysis, Clinical Nephrology 71 (2009), 405-412.